IMF Videos Search Content For Healthcare Professional (122) Healthcare Provider (122) Care Partner (75) Patient (74) Series - Any - ASCO/EHA (49) ASH (60) Ask Dr. Durie (16) Black Swan Research Initiative (5) Community Workshops (4) Emerging Therapies (6) Facebook Live (10) Health Equity (2) IMWG (3) Inspirational (3) Living Well with Myeloma (4) Myeloma in a Minute (1) Myeloma Made Simple (3) Patient & Family Webinar (4) Q&A (7) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (65) High-Risk Myeloma (42) High-risk Smoldering Myeloma (34) Late Relapse (4–6 Lines of Therapy) (81) MGUS (35) Newly Diagnosed (Pre-Treatment or First Treatment) (64) Smoldering Myeloma (50) Types of Therapy Immunomodulatory drugs (IMiDs) (58) Immunotherapies (CAR T; BiTE, etc.) (93) Monoclonal antibodies (48) Proteasome inhibitors (43) Stem cell transplant (40) Steroids (41) Supportive Care (36) Year Published 2026 (16) 2025 (38) 2024 (58) 2023 (39) 2022 (10) 2021 (7) 2020 (1) 2019 (9) 2018 (2) 2017 (1) 2016 (3) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (15) Dr. María-Victoria Mateos (6) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Dr. Saad Usmani (3) Dr. Sigurður Kristinsson (3) Dr. Shaji Kumar (2) Dr. Urvi A. Shah (2) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Anitocabtagene Autoleucel iMMagine-1 Trial: Exceptional Safety and Durability in Relapsed Myeloma January 16, 2026 ASH MajesTEC-3: Teclistamab-Daratumumab Establishes New Standard of Care in Early Relapsed Myeloma January 12, 2026 ASH KLN-1010 In Vivo CAR-T Therapy: Revolutionary Off-the-Shelf Treatment for Multiple Myeloma January 9, 2026 ASH Top Myeloma Research Presented at ASH 2025: Easy-to-Understand Insights for Patients and Care Partners January 7, 2026 ASH Cilta-cel Safety Enhancement: Modifiable Risk Factors for Delayed Neurotoxicity and Non-Relapse Mortality December 19, 2025 ASH Multiple Myeloma Breakthroughs and Patient Voices from ASH in Orlando December 8, 2025 Facebook Live Can We Prevent Multiple Myeloma? | Dr. Shaji Kumar on Risk, MGUS, Early Treatment November 29, 2025 IMWG IMF Virtual Myeloma Community Workshop (MCW): “What’s the ‘Right’ Answer? – Controversies in Myeloma” November 17, 2025 Community Workshops High-Risk Smoldering Myeloma & New Frontline Treatments: What Patients Need to Know | IMS Part 2 of 2 October 30, 2025 Emerging Therapies Terrence & Toni’s Multiple Myeloma Journey October 15, 2025 Inspirational Joan’s Myeloma Journey | Clinical Trials, Family Support, and Living with Myeloma October 9, 2025 Inspirational Diagnosed with Myeloma at 34: Thomas Shares His Stem Cell Transplant & Clinical Trial Experience October 1, 2025 Inspirational Load More
